SEC Company Response from MICRUS ENDOVASCULAR CORP (CIK 0001028318) — Jun 13, 2005

MICRUS ENDOVASCULAR CORP (CIK 0001028318)
Date: June 13, 2005 · CIK: 0001028318 · Accession: 0000891618-05-000423

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-123154

Date

June 13, 2005

Author

MICRUS ENDOVASCULAR

Form

CORRESP

Company

MICRUS ENDOVASCULAR CORP (CIK 0001028318)

Letter

United States Securities and Exchange Commission Division of Corporate Finance Mail Stop 0306 450 Fifth Street, N.W. Washington DC, 20549 Re: Micrus Endovascular Corporation

Dear Mr. Heyliger:

Micrus Endovascular Corporation (the “Company”) is submitting this letter to the Securities and Exchange Commission (the “Commission”) in connection with the request the Company submitted to the Commission earlier today requesting that its Registration Statement on Form S-1 (Registration No. 333-123154) be declared effective on Wednesday, June 15, 2005 at 3:00 p.m. Eastern Daylight Time.

The Company hereby acknowledges the following:

1. The Commission’s declaration of the effectiveness of the Registration Statement does not foreclose the Commission from taking any action with respect to the filing of the Registration Statement.

2. The Commission’s declaration of the effectiveness of the Registration Statement does not relieve the Company from its responsibility for the adequacy and accuracy of the disclosure set forth in the Registration Statement; and

3. The Company may not assert the comments provided by the Commission to the Company in connection with the filing of the Registration Statement as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Sincerely,
MICRUS ENDOVASCULAR
CORPORATION

Show Raw Text

CORRESP
1
filename1.htm

corresp

June 13, 2005

via
federal express

Adelaja K. Heyliger

United States Securities and Exchange Commission

Division of Corporate Finance

Mail Stop 0306

450 Fifth Street, N.W.

Washington DC, 20549

Re:   Micrus
Endovascular Corporation

Dear Mr. Heyliger:

     Micrus
Endovascular Corporation (the “Company”) is submitting this
letter to the Securities and Exchange Commission (the
“Commission”) in connection with the request the Company
submitted to the Commission earlier today requesting that its
Registration Statement on Form S-1 (Registration
No. 333-123154) be declared effective on Wednesday, June 15,
2005 at 3:00 p.m. Eastern Daylight Time.

     The
Company hereby acknowledges the following:

     1.
The Commission’s declaration of the effectiveness of the
Registration Statement does not foreclose the Commission from taking
any action with respect to the filing of the Registration Statement.

     2.
The Commission’s declaration of the effectiveness of the
Registration Statement does not relieve the Company from its
responsibility for the adequacy and accuracy of the disclosure set
forth in the Registration Statement; and

     3.
The Company may not assert the comments provided by the Commission to
the Company in connection with the filing of the Registration
Statement as a defense in any proceeding initiated by the Commission
or any person under the federal securities laws of the United States.

    Sincerely,

    MICRUS ENDOVASCULAR
CORPORATION

    By:

/s/
Robert A. Stern

Robert A. Stern

Executive Vice President and

Chief Financial Officer

SecProbe.io